Peter Andersen Selected Research

Infections

5/2024	Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccination.
1/2022	Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model.
2/2021	In vivo antigen expression regulates CD4 T cell differentiation and vaccine efficacy against Mycobacterium tuberculosis infection.
1/2021	In Vivo Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection.
1/2020	CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection.
1/2020	Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection.
1/2020	Diagnostic Accuracy of Interferon Gamma-Induced Protein 10 mRNA Release Assay for Tuberculosis.
1/2020	Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal priming.
10/2019	Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube.
10/2019	HCV p7 as a novel vaccine-target inducing multifunctional CD4+ and CD8+ T-cells targeting liver cells expressing the viral antigen.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Andersen Research Topics

Disease

112	Tuberculosis (Tuberculoses) 01/2023 - 02/2002
103	Infections 05/2024 - 06/2002
12	Neoplasms (Cancer) 01/2024 - 10/2007
8	Human Influenza (Influenza) 01/2023 - 09/2008
8	Squamous Cell Carcinoma of Head and Neck 12/2022 - 05/2006
8	Latent Tuberculosis 01/2020 - 04/2003
7	Pulmonary Tuberculosis 01/2018 - 02/2002
7	Latent Infection 01/2017 - 06/2004
6	Inflammation (Inflammations) 01/2023 - 11/2009
4	Fibrosis (Cirrhosis) 01/2023 - 10/2019
4	Pain (Aches) 01/2022 - 01/2017
4	Necrosis 01/2021 - 01/2010
4	Persistent Infection 01/2020 - 04/2014
4	Bovine Tuberculosis 10/2009 - 07/2003
3	Liver Diseases (Liver Disease) 01/2023 - 01/2023
3	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2023
3	Weight Loss (Weight Reduction) 01/2023 - 08/2011
3	Parasitic Diseases (Parasitic Disease) 01/2017 - 06/2012
3	Malaria 01/2017 - 09/2008
3	Reproductive Tract Infections 09/2015 - 04/2012
3	Melanoma (Melanoma, Malignant) 11/2014 - 01/2008
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2023
2	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 11/2018
2	Bites and Stings (Sting) 01/2021 - 03/2016
2	Disease Progression 01/2020 - 02/2013
2	Sarcopenia 01/2020 - 12/2017
2	Wounds and Injuries (Trauma) 12/2019 - 12/2017
2	Chronic Hepatitis C 10/2019 - 01/2017
2	Postoperative Pain 11/2018 - 11/2017
2	Cardiomyopathies (Cardiomyopathy) 10/2017 - 04/2016
2	Fever (Fevers) 01/2017 - 01/2017
2	Hemorrhage 01/2017 - 11/2013
2	Communicable Diseases (Infectious Diseases) 05/2015 - 05/2010
2	Poliomyelitis (Polio) 04/2015 - 01/2014
2	Chlamydia Infections 02/2014 - 04/2012
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2013 - 06/2012
2	Hypersensitivity (Allergy) 04/2008 - 08/2003
1	Atrial Fibrillation 01/2023
1	Cardiac Arrhythmias (Arrythmia) 01/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023
1	Alcoholism (Alcohol Abuse) 01/2023
1	Fistula 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023

Drug/Important Bio-Agent (IBA)

90	VaccinesIBA 05/2024 - 05/2002
57	AntigensIBA 01/2023 - 02/2002
38	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2002
25	Subunit VaccinesIBA 11/2021 - 06/2002
24	Tuberculin (PPD)IBA 01/2020 - 04/2003
15	AerosolsIBA 02/2021 - 06/2002
13	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 11/2003
12	CytokinesIBA 10/2019 - 06/2004
11	Peptides (Polypeptides)IBA 05/2024 - 07/2002
11	BCG Vaccine FDA Link 10/2020 - 02/2002
11	Liposomes (Liposome)IBA 01/2017 - 03/2007
10	EpitopesIBA 05/2024 - 12/2006
8	LipidsIBA 01/2023 - 10/2004
7	AntibodiesIBA 05/2024 - 01/2005
7	Immunoglobulin G (IgG)IBA 01/2022 - 05/2004
7	Indicators and Reagents (Reagents)IBA 06/2013 - 02/2002
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2006
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2012
6	Immunoglobulin A (IgA)IBA 01/2020 - 01/2011
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2012 - 07/2007
5	Interleukin-4 (Interleukin 4)IBA 01/2012 - 06/2004
4	Membrane Proteins (Integral Membrane Proteins)IBA 05/2024 - 09/2008
4	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2023 - 01/2010
4	dimethyldioctadecylammonium (dimethyldioctadecylammonium chloride)IBA 01/2023 - 11/2006
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017 - 06/2004
4	Interleukin-2 (IL2)IBA 01/2013 - 07/2007
3	Hemagglutinins (Hemagglutinin)IBA 01/2023 - 08/2011
3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 06/2008
3	GoldIBA 12/2018 - 01/2007
3	Recombinant ProteinsIBA 01/2017 - 11/2003
3	Neutralizing AntibodiesIBA 01/2017 - 09/2015
3	TrehaloseIBA 06/2014 - 04/2012
2	Cord FactorsIBA 01/2023 - 06/2012
2	Opioid Analgesics (Opioids)IBA 01/2022 - 11/2018
2	PolymersIBA 01/2021 - 03/2016
2	Immunodominant EpitopesIBA 01/2020 - 08/2009
2	InterferonsIBA 01/2020 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 10/2018
2	IC31 adjuvantIBA 01/2017 - 05/2008
2	hydroxide ionIBA 04/2015 - 01/2010
2	OvalbuminIBA 06/2014 - 06/2012
2	monophosphoryl lipid AIBA 04/2012 - 11/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2012 - 01/2010
2	Interleukin-12 (IL 12)IBA 01/2012 - 08/2011
2	epidermal growth factor receptor VIIIIBA 02/2009 - 01/2008
2	Tuberculosis VaccinesIBA 06/2008 - 10/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2008 - 10/2007
2	Virulence Factors (Pathogenicity Factors)IBA 05/2006 - 06/2004

Therapy/Procedure

8	Therapeutics 01/2024 - 05/2006
2	Transplantation 01/2022 - 10/2017
2	Radiotherapy 01/2020 - 11/2014
2	Drug Therapy (Chemotherapy) 01/2017 - 04/2008
2	Aftercare (After-Treatment) 06/2012 - 01/2012
2	Mucosal Administration 01/2007 - 11/2006
1	Immunotherapy 01/2024
1	Punctures 01/2023
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2023